ECONOMYNEXT – There will be no shortage of medicines in Sri Lanka due to the COVID-19 situation in India, the Sri Lanka Chamber of the Pharmaceutical Industry (SLCPI) said today.
“The orders placed with our manufacturing partners and principals in India and other countries are being fulfilled and we will ensure that our consumers will continue to have access to quality medicines, seamlessly,” the SLCPI said in a press release.
There has been speculation of a drug shortage in Sri Lanka as the pandemic continues to wreak havoc in neighbouring India, known as the pharmacy of the world.
“SLCPI and its member companies reassure the availability of adequate supplies of medicines for those in need of them,” the statement said.
It said that it is closely monitoring orders and inventories, adding that the needs of the public are a priority, especially those in the non-communicable diseases (NCDs) segment.
SLCPI represents over 60 major private importers of pharmaceuticals in the country, accounting for 85% of Sri Lanka’s medicines market.
SLCPI’s stakeholders supply the country with 800 molecules from 364 manufacturers from across the world, the release said.
The body urged the public to not panic.
“We will ensure that access to medicines will continue for those that need them and urge the public to be sensible and judicious in their reaction to the current situation.”
A spokesperson for SLCPI was unavailable for comment. (Colombo/Apr29/2021)